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S U M M A R Y
Background: Varicella vaccine is available for private purchase in Beijing, with single dose recommended
for children aged 12 months before 2013. Despite the success achieved in reducing varicella incidence,
varicella outbreaks continued to occur, including in schools and kindergartens among highly vaccinated
children. We investigated a varicella outbreak in a preschool with high varicella vaccination coverage in
Haidian district, Beijing.
Methods: Through questionnaires, data including children’s medical and vaccination history were
collected from their parents. A case of varicella was deﬁned as an acute, generalized, maculopapu-
lovesicular rash without other apparent cause in a child in the preschool from March 10 through March
29, 2010. Attack rates in vaccinated and unvaccinated children were calculated, and the analyses of
vaccine effectiveness (VE) and of risk factors for breakthrough disease (varicella occurring >42 days after
vaccination) were conducted.
Results: A total of 12 cases occurred during the outbreak, and ten of them (83.3%) had breakthrough
varicella. The index case with mild varicella occurred in a child who had been vaccinated four years
previously. Questionnaires were returned for all of 150 children in the preschool. Of all the 150 children,
144 (96.0%) had no prior history of varicella disease. Among these children, 135(93.7%) had received
single-dose varicella vaccine before the outbreak. VE was 84.5% [95% conﬁdence interval (CI):
62.8%93.5%] in preventing varicella of any severity, and VE was 92.2% (95% CI: 81.4%96.8%) against
moderate to severe varicella. Age at vaccination (<15 months vs. 15 months) and time since
vaccination before the outbreak (<3 years vs. 3 years) were not associated with the increased risk of
breakthrough varicella(P=0.124 and 1, respectively). All the varicella cases with vaccination history
veriﬁed through immunization records had received varicella vaccine and measles-mumps-rubella
vaccine >30 days apart.
Conclusions: Breakthrough infection with fever in vaccinated person may be as infectious as varicella in
unvaccinated persons. High single-dose varicella vaccination coverage is effective in reducing varicella
incidence, but not sufﬁcient to prevent outbreak. To control varicella outbreak a second dose may
deserve additional consideration.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Varicella is a highly contagious disease resulting from primary
infection caused by varicella-zoster virus(VZV), with secondary
attack rates of 60%-90% among susceptible household contacts.1,2
In the absence of a varicella vaccination program, most people
become infected by mid-adulthood.3 A live attenuated varicella
vaccine (Oka strain) was developed in 19744 and licenced for use in
Beijing in 1997,5 and since then this vaccine has been shown to be
highly effective in preventing varicella disease.6,7 Currently,* Corresponding author. Tel.: +86 10 82405733; fax: +86 10 82405623.
E-mail address: fu-jiye@163.com (J. Fu).
http://dx.doi.org/10.1016/j.ijid.2015.06.003
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).varicella vaccine is available for private purchase but not included
in national or provincial routine immunization programs in China.
To control school-based varicella outbreaks, single-dose vaccina-
tion has been provided free of charge by the Beijing government
since 2006 to unvaccinated children in schools and kindergartens
in Beijing.8 Varicella vaccine is administrated immediately after an
outbreak is identiﬁed, and this strategy in some settings has been
demonstrated to be effective.9,10 Despite the success achieved in
reducing varicella incidence, outbreaks continued to occur,
including in schools and kindergartens among highly vaccinated
populations.5,11
In March 2010, the Haidian Center for Disease Control and
Prevention (CDC) was notiﬁed of a suspected varicella outbreak inciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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>90% in Haidian district, Beijing. The Haidian CDC investigated
the outbreak, and then conducted a retrospective cohort study
aimed to (1) determine the coverage of varicella vaccination
among children, (2) estimate the effectiveness of 1-dose varicella
vaccine and (3) evaluate the potential risk factors for break-
through disease.
2. Methods
2.1. Outbreak setting
The outbreak occurred in a private preschool in Haidian district,
Beijing. During the outbreak, 150 children, mainly locals, were
attending the preschool which was located in the ground ﬂoor of a
residential building. There were six classrooms and a large room,
where the children attending the preschool napped together, and
with 15 staff members in the preschool. Approximately 90% of
children were vaccinated.
2.2. Epidemiological investigation
Questionnaires were distributed to all of the children’s parents
in the preschool. Data about demographics, history of varicella
disease, and vaccination status, including dates of vaccination,
were collected. Varicella vaccination history was veriﬁed through
immunization records or recalled by parents. Parents of varicella
cases were contacted by telephone to collect information about the
possible source and setting of exposure, clinical course of illness
(e.g., date of rash onset, duration of rash, number of lesions,
presence of fever, complications), and parental consent to collect
blood specimens for testing. As a public health response to an
outbreak, this investigation was determined not to be a human-
subjects research.
2.3. Case deﬁnitions
A case of varicella was deﬁned as an acute, generalized,
maculopapulovesicular rash without other apparent cause8 in a
child in the preschool from March 10 to March 29, 2010. A varicella
outbreak was deﬁned as 5 cases of varicella occurred in a
kindergarten or school within one week.8 Varicella disease was
categorized as mild (<50 lesions), moderate (50-500 lesions), and
severe (>500 lesions or presence of complications or hospitaliza-
tion). Breakthrough disease was deﬁned as varicella occurring >42
days after vaccination.12
2.4. Vaccine effectiveness (VE)
The attack rates in unvaccinated children (ARU) and vaccinated
children (ARV) were calculated. Then VE was calculated as
VE=(ARU-ARV)/ARU100%.13 Conﬁdence interval (CI) for the VE
was calculated as described previously.14 A case of varicella with
mild disease was considered as a ‘‘noncase’’ patient when VE was
calculated against moderate to severe variclla. Children with prior
history of varicella before the outbreak, vaccinated less than
42 days before disease onset, vaccinated during the outbreak, and
vaccination history not veriﬁed through immunization records,
were excluded from VE analysis.
2.5. Risk factors for breakthrough varicella
We evaluated potential risk factors for breakthrough disease
among vaccinated children without prior history of varicella,
including age at the start of the outbreak, gender, years since
vaccination calculated from the start of the outbreak, and age atvaccination. For children with history of varicella vaccination
veriﬁed through immunization records, we determined whether
the varicella vaccine and measles-mumps-rubella (MMR) vaccine
had been administered within 30 days.
2.6. Laboratory investigations
Blood specimens of three varicella cases were collected and
tested for VZV IgM antibodies using a commercial enzyme linked
immunosorbent assay (ELISA, Virion/Serion, Wu¨rzburg, Germany),
with whole extracted VZV proteins as a source of antigen.15 Testing
was performed according to the manufacturer’s instructions at the
Haidian CDC net laboratory.
2.7. Statistical analysis
Data were entered into EpiData software (EpiData Association,
Odense, Denmark). Pearson’s chi-squared test and Fisher’s exact
test for categorical covariates were used to compare proportions,
and the Wilcoxon rank-sum test was used to compare medians. All
statistical analyses were performed with SPSS software (version
13.0; SPSS, Inc., Chicago, IL). 2-sided P values were reported with a
signiﬁcance level of P<0.05.
3. Results
3.1. Study population characteristics
During the outbreak, a total of 150 children in six classrooms
were enrolled in the preschool. No staff developed varicella and all
analyses were restricted to children. Questionnaires were com-
pleted and returned for all 150 children. Of all the 150 children, six
(4.0%) with prior history of varicella disease were excluded for
analysis (Figure 1). Among the 144 children without history of
varicella disease, 135(93.7%) had received vaccines before the
outbreak and nine (6.3%) were unvaccinated. Four of the
unvaccinated children vaccinated during the outbreak were
excluded from further analysis; and none of them developed
vacricella. The remanding 140 children without prior varicella
history ranged in age from 5.40 to 6.96 years (median: 5.92 years);
67 (47.9%) were females. Of the 135 vaccinated children, 129
(95.5%) were veriﬁed through immunization records, and six (4.5%,
containing two cases of varicella), which were excluded for VE and
risk factors analysis, were recalled by parents. Among single-dose
vaccine recipients, the average age at vaccination was 18 months
(median: 15 months; range: 12 to 60 months) and the average time
since vaccination before the outbreak was 51 months (median: 54;
range: 11 to 65 months).
3.2. Investigation of the index case
The index patient was a vaccinated, 5.5-year-old boy (born on
July 6, 2004) who had an onset of rash on March 10, 2010,
approximately 4.5 years after vaccination (July 13, 2005). He
attended the preschool on the two days before the onset of rash
and brieﬂy on the morning on which his rash erupted, before he
was taken home and diagnosed clinically. He was mildly ill, with a
generalized rash consisting of <50 lesions and a fever of 38.1 8C,
and had no complications. On the two days the child napped with
other children in the large room as usual. His only known exposure
to VZV recalled by his parents was contact with a varicella case in
the waiting area of the hospital about on February 25, 2010
(2 weeks before the onset of rash in the index patient). He was not
tested for VZV IgM, as there was no parental consent for blood
collection.
Figure 1. Vaccination and varicella cases status, a varicella outbreak in a preschool in Haidian district, Beijing (n=150).
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The outbreak lasted from March 10 through March 29, 2010
(Figure 2). Overall 12 cases of varicella were distributed in all six
classes and no cases occurred in children with prior history of
varicella disease. The median age of children with varicella was
5.83 years (range: 5.44 to 6.13 years). Five (41.7%) of these children
were girls. Ten cases (83.3%) occurred in vaccinated children and
two cases (16.7%) in unvaccinated children. Overall, nine cases
(75.0%) of varicella were mild, and three (25.0%) were moderate,
and none was severe.
3.4. Outbreak control measures
Children with varicella were excluded from preschool until
lesions crusted over. On March 27, 2010, varicella vaccinations
were provided to four of the nine unvaccinated children. And theFigure 2. Number of children with varicella in the outbreak, by date of rash oclassrooms, nap room, indoor play area, and washing room were
disinfected when the outbreak was detected. Publicity on
prevention and control of varicella was implemented among the
children’s parents and the staffs in the preschool.
3.5. Laboratory analysis
Three varicella cases were conﬁrmed by serological testing with
VZV IgM positive, and two of them were vaccinated and the
remaining one was unvaccinated. The remainders were epidemio-
logically linked.
3.6. VE and risk factors for breakthrough disease
The attack rates of varicella among unvaccinated and vaccinat-
ed children were 40.0% (two of ﬁve) and 6.2% (eight of 129),
respectively. The attack rates of moderate to severe varicellanset and vaccination in the preschool in Haidian district, Beijing (n=12).
Table 1
Univariate analysis of potential risk factors for breakthrough varicella (n=129a)
Variable Breakthrough varicella
(N=8), n(%)
Well
(N=121), n(%)
P
Age (years) 0.891b
Range 5.68-6.13 5.40-6.72
Median 5.90 5.92
Mean 5.90 5.94
Gender 0.475c
Males 3(4.4) 65(95.6)
Females 5(8.2) 56(91.8)
Age at vaccination 0.124d
<15 months 7(9.9) 64(90.1)
15 months 1(1.7) 57(98.3)
Time since vaccination before outbreak 1c
<3 years 0(0) 5(100.0)
3 years 8(6.4) 116(93.6)
Time between varicella and MMR vaccinatione 1c
<30 days 0(0) 2(100.0)
30 days 8(8.1) 91(91.9)
Abbreviation: MMR: measles, mumps, and rubella.
a Six children whose vaccination history recalled by parents were excluded from analysis.
b Wilcoxon rank-sum test.
c Fisher’s exact test.
d Continuity correction for Pearson’s chi-squared test.
e 101 children’s immunization records of MMR vaccination were available.
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ﬁve) and 1.6% (two of 129). VE was 84.5% (95%CI: 62.8%93.5%)
in preventing varicella of any severity and 92.2% (95%CI:
81.4%96.8%) against moderate to severe varicella. In single-
dose recipients, age at vaccination (<15 months vs. 15 months)
and time since vaccination before the outbreak (<3 years vs. 3
years) were not associated with the increased risk of break-
through varicella (P=0.124 and 1, respectively, Table 1). All the
vaccinated cases with vaccination veriﬁed through immunization
records had received the varicella vaccine and the MMR vaccine
>30 days apart.
4. Discussion
As previously described, compared with natural varicella,
breakthrough disease is most commonly a milder, modiﬁed
infection.16–19 Children with breakthrough varicella can still
transmit the virus, although transmission is less frequent than
from unvaccinated children with varicella. Therefore, its public
health signiﬁcance depends not only on its severity, but also on its
potential for transmission. In school settings transmission
between vaccinated children and adolescents raises the potential
for sustained varicella transmission, even when vaccine coverage is
high.17,18 In this outbreak, the index case with breakthrough
varicella disseminated VZV among all six classes in the preschool,
indicating that breakthrough disease with fever may be as
infectious as varicella in unvaccinated persons. As the rashes in
the index case were atypical maculopapulea rather than vesicula,
the VZV was probably spread by airborne droplets from respiratory
secretions. In a previous study of varicella transmission in
households,20 persons with breakthrough disease were half as
contagious as unvaccinated persons with varicella. Due to the
intensity and duration of exposure, the transmission of break-
through varicella to susceptible persons may vary in clustered
facilities from households. Hence, further studies are needed to
acquire transmission of breakthrough disease in schools and
kindergartens population.
Previous investigations found vaccination at <15 months of
age21,22 as a risk factor for breakthrough varicella. On the contrary,
it was not associated with increased risk of breakthrough disease in
our study. Previous retrospective outbreak-based studies7,11,23–25
indicated that children vaccinated three (or ﬁve) years and morebefore exposure were at increased risk for breakthrough infection
during the outbreaks, suggesting a waning of immunity. Con-
versely, if waning immunity were a major risk factor, the VE would
be expected to decline steadily with time, but the Vazquez et al.’s
study found VE to be stable during the second through eighth years
after vaccination.19 And in another study conducted from
1995 through 2009 in the United States,26 Roger Baxter et al.
conﬁrmed that 1-dose varicella vaccine provided excellent
protection against moderate to severe disease, with no waning
noted over a 14-year period. In our study, time since vaccination
(three years and more before the outbreak) was not associated
with an increased risk of breakthrough varicella, either. In this
outbreak, no vaccinated cases had received MMR vaccine and
varicella vaccine <30 days apart.
We found a high effectiveness of the varicella vaccine during
the outbreak. Efﬁcacy of 1-dose varicella vaccine was high in
clinical trials and the VE was conﬁrmed in postlicensure studies to
be 80% to 94% in preventing varicella and highly effective in
preventing moderate to severe disease.26 The 84.5% VE that we
noted was similar to the VE found by Vazquez et al. (85%) and
Izurieta et al. (86%).27,28 The VE against combined moderate and
severe varicella in our study (92.2%) was similar to the VE (86%-
100%) based on varicella outbreak investigation reported in a
review on varicella VE in the US vaccination program.29 These
ﬁndings support the observation that the vaccine is highly effective
but is not guaranteed to prevent varicella. Our study also indicated
93.7% vaccination coverage was not sufﬁcient to prevent outbreak
in the preschool population. Modeling predicts that varicella
vaccination coverage will need to reach 97% to achieve the
background immunity required to prevent outbreaks.30 But in
previous studies7,31,32 even with 98.3-100% varicella vaccination
coverage outbreaks still occurred. These outbreak investigations
highlight challenge related to the control of varicella outbreaks
with the single-dose varicella vaccination program and the need
for further prevention of varicella including through 2-dose
vaccination.
The ﬁndings from our study and other varicella outbreak
investigations, and other scientiﬁc evidence were taken into
account when, in November 2012, the Beijing CDC adapted
technical guidelines33 and recommended that children 18
months of age should be administrated one dose of varicella
vaccine and a second dose at 4 years of age. The guideline also
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given to children and adolescents, who previously had received
one dose. As no long-term data are available on the duration of
immunity afforded by the second dose of vaccine in China, further
study should be conducted to evaluate VE of the 2-dose policy.
Two strengths distinguish this investigation. Excellent response
rates contributed to completeness of case ascertainment and the
veriﬁcation to immunization records got the children’s vaccination
history correctly, and both of these helped minimize the recall bias
in estimation of VE.
Several limitations should be considered in interpreting our
ﬁndings. First, the small number of unvaccinated children (n=5)
and unvaccinated cases (n=2) makes it approximately impossible
to get a reliable VE estimation using the attack rate in the
unvaccinated children from this preschool, and limited our ability
to explore the effects of the time since vaccination and the age at
vaccination. Second, due to the population conﬁned to the children
in preschool, we could not acquire the association between
breakthrough disease and ﬁve years and more since vaccination in
this study. Furthermore, most cases were not laboratory con-
ﬁrmed, and any misdiagnosis of varicella could result in over-
estimated or underestimated VE. Rashes mistaken for
breakthrough disease (such as insect bites or enteroviral infec-
tions) could have falsely lowered the estimate of VE, although
these conditions occur infrequently in early spring. Subtle
presentations of breakthrough disease that were not clinically
recognized could have led to a false elevation of the estimate of VE.
5. Conclusions
Breakthrough infection with fever in vaccinated person may be
as infectious as varicella in unvaccinated persons. As the level of
varicella vaccination heightens and varicella morbidity declines,
the transmissions to susceptible persons due to breakthrough
varicella should be assessed. High single-dose varicella vaccination
coverage is effective in reducing varicella incidence, but not
sufﬁcient to prevent outbreak. To control varicella outbreak, the
need for a second dose of varicella vaccination may deserve
additional consideration, although the effect of this policy will
need to be evaluated in the future.
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